title: Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.
abstract: Biomarkers for active tuberculosis (TB) are urgently needed. Mycobacteria produce membrane vesicles (MVs) that contain concentrated immune-modulatory factors that are released into the host. We evaluated the human immune responses to BCG and Mycobacterium tuberculosis MVs to characterize the antibody responses and identify potentially novel TB biomarkers. Serological responses to MVs were evaluated by ELISAs and immunoblots with sera from 16 sputum smear-positive, 12 smear-negative HIV uninfected pulmonary TB patients and 16 BCG vaccinated Tuberculin skin-test positive controls with and without latent tuberculosis infection. MVs from both BCG and M. tuberculosis induced similar responses and were strongly immunogenic in TB patients but not in controls. Several MV-associated antigens appear to induce robust antibody responses, in particular the arabinomanan portion of the cell wall glycolipid lipoarabinomannan. Three proteins at ≈ 36, 25, and 23 kDa were simultaneously recognized by sera from 16/16 smear-positive, 9/12 smear-negative TB patients and 0/16 controls. These results provide promise and encouragement that antibody responses to proteins enriched in MVs of pathogenic mycobacteria may constitute a novel TB biomarker signature that could have diagnostic information.
authors.affiliation: Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
authors.forename: Anke
authors.initials: A
authors.lastname: Ziegenbalg
authors.forename: Rafael
authors.initials: R
authors.lastname: Prados-Rosales
authors.forename: Elisabeth R
authors.initials: ER
authors.lastname: Jenny-Avital
authors.forename: Ryung S
authors.initials: RS
authors.lastname: Kim
authors.forename: Arturo
authors.initials: A
authors.lastname: Casadevall
authors.forename: Jacqueline M
authors.initials: JM
authors.lastname: Achkar
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000907:Antibodies, Bacterial / Q000096:biosynthesis* / Q000097:blood; D000942:Antigens, Bacterial / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D022162:Cytoplasmic Vesicles / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D007136:Immunoglobulins / Q000096:biosynthesis / Q000097:blood; D008875:Middle Aged; D009163:Mycobacterium bovis / Q000276:immunology*; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D012680:Sensitivity and Specificity; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis*; D055815:Young Adult
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D015415:Biomarkers; D007136:Immunoglobulins
references.citation: Clin Dev Immunol. 2007;2007:39245
references.pmid: 18317528
references.citation: Clin Vaccine Immunol. 2012 Feb;19(2):198-208
references.pmid: 22169090
references.citation: J Clin Microbiol. 2005 Oct;43(10):5065-8
references.pmid: 16207963
references.citation: Microbes Infect. 2006 Apr;8(5):1252-9
references.pmid: 16702016
references.citation: Vaccine. 2011 Aug 5;29(34):5705-10
references.pmid: 21679737
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15688-93
references.pmid: 9861031
references.citation: Lancet Infect Dis. 2006 Sep;6(9):570-81
references.pmid: 16931408
references.citation: Nature. 2004 Apr 1;428(6982):487-92
references.pmid: 15057821
references.citation: Lancet. 2011 Apr 30;377(9776):1495-505
references.pmid: 21507477
references.citation: Clin Diagn Lab Immunol. 2001 Jan;8(1):166-9
references.pmid: 11139212
references.citation: Clin Exp Immunol. 2004 Oct;138(1):30-8
references.pmid: 15373902
references.citation: Postgrad Med J. 2007 Nov;83(985):705-12
references.pmid: 17989270
references.citation: Lancet. 2010 May 29;375(9729):1920-37
references.pmid: 20488517
references.citation: J Clin Microbiol. 2010 Jan;48(1):229-37
references.pmid: 19864480
references.citation: Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19002-7
references.pmid: 20956325
references.citation: J Immunol. 2011 Mar 1;186(5):3113-9
references.pmid: 21257971
references.citation: N Engl J Med. 2010 Sep 9;363(11):1005-15
references.pmid: 20825313
references.citation: FEMS Immunol Med Microbiol. 2003 May 25;36(3):199-205
references.pmid: 12738392
references.citation: Arch Dis Child. 2011 Aug;96(8):744-51
references.pmid: 21596727
references.citation: Clin Diagn Lab Immunol. 2003 Jul;10(4):612-5
references.pmid: 12853393
references.citation: J Infect Dis. 2012 May 15;205 Suppl 2:S159-68
references.pmid: 22476718
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: Lett Appl Microbiol. 2002;34(4):233-7
references.pmid: 11940150
references.citation: Infect Immun. 2008 Oct;76(10):4554-63
references.pmid: 18678672
references.citation: Clin Diagn Lab Immunol. 2003 Sep;10(5):793-6
references.pmid: 12965906
references.citation: Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1376-95
references.pmid: 10764337
references.citation: Vaccine. 2011 Oct 26;29(46):8381-9
references.pmid: 21871517
references.citation: FEMS Immunol Med Microbiol. 2004 Jun 1;41(2):93-100
references.pmid: 15145452
references.citation: Int J Med Microbiol. 2009 Aug;299(6):447-52
references.pmid: 19157977
references.citation: Vaccine. 2007 Apr 20;25(16):3080-4
references.pmid: 17287053
references.citation: Infect Immun. 2005 Sep;73(9):6101-9
references.pmid: 16113331
references.citation: Cell Host Microbe. 2013 Mar 13;13(3):250-62
references.pmid: 23498951
references.citation: Nature. 2001 Jul 12;412(6843):190-4
references.pmid: 11449276
references.citation: J Clin Microbiol. 1995 Feb;33(2):419-27
references.pmid: 7714202
references.citation: Clin Vaccine Immunol. 2010 Mar;17(3):384-92
references.pmid: 20071491
references.citation: Tuberculosis (Edinb). 2006 May-Jul;86(3-4):268-72
references.pmid: 16677862
references.citation: Clin Chem. 1993 Apr;39(4):561-77
references.pmid: 8472349
references.citation: J Immunol. 2007 Dec 1;179(11):7692-701
references.pmid: 18025215
references.citation: PLoS Med. 2011 Aug;8(8):e1001062
references.pmid: 21857806
references.citation: Int J Tuberc Lung Dis. 2012 Sep;16(9):1140-8
references.pmid: 22871324
references.citation: J Bacteriol. 1999 Aug;181(16):4725-33
references.pmid: 10438737
references.citation: J Neuroophthalmol. 2008 Mar;28(1):5-11
references.pmid: 18347451
references.citation: Vaccine. 2011 Oct 26;29(46):8222-9
references.pmid: 21911022
references.citation: JAMA. 1999 Sep 15;282(11):1061-6
references.pmid: 10493205
references.citation: Clin Vaccine Immunol. 2009 Feb;16(2):260-76
references.pmid: 19052159
references.citation: Infect Immun. 2010 Dec;78(12):5116-25
references.pmid: 20837713
references.citation: Clin Vaccine Immunol. 2007 Jul;14(7):830-8
references.pmid: 17494638
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14703-8
references.pmid: 20668240
references.citation: PLoS Med. 2007 Jun;4(6):e202
references.pmid: 17564490
references.citation: Lancet Infect Dis. 2010 Dec;10(12):886-92
references.pmid: 21050822
references.citation: Immunology. 2004 Mar;111(3):328-33
references.pmid: 15009434
references.citation: Genes Dev. 2005 Nov 15;19(22):2645-55
references.pmid: 16291643
references.citation: FEMS Immunol Med Microbiol. 2007 Feb;49(1):13-21
references.pmid: 17266710
references.citation: J Clin Invest. 2011 Apr;121(4):1471-83
references.pmid: 21364279
references.citation: Tuberculosis (Edinb). 2009 Jan;89(1):91-4
references.pmid: 18986840